SANGUI BIOTECH INTERNATIONAL INC: 10-Q filed 2013-05-20
What SANGUI BIOTECH INTERNATIONAL INC reported in its quarterly report filed 2013-05-20 (fiscal Q3 2013): 26 published measures, 70 facts as tagged in accession 0001104280-13-000009.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2013-05-20
- Fiscal period
- fiscal Q3 2013
- Accession
- 0001104280-13-000009 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All SANGUI BIOTECH INTERNATIONAL INC filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 1,638,284 | USD | |
| At 2012-06-30 | 1,127,725 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 1,426,865 | USD | |
| At 2012-06-30 | 959,374 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 77,722 | USD | |
| At 2012-06-30 | 238,639 | USD | |
| At 2012-03-31 | 14,739 | USD | |
| At 2011-06-30 | 122,619 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | -130,606 | USD | 90 |
| 2012-07-01 to 2013-03-31 | -826,906 | USD | 274 |
| 2012-01-01 to 2012-03-31 | -73,723 | USD | 91 |
| 2011-07-01 to 2012-03-31 | -631,439 | USD | 275 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2013-03-31 | -505,698 | USD | 274 |
| 2011-07-01 to 2012-03-31 | -460,596 | USD | 275 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | 33,388 | USD | 90 |
| 2012-07-01 to 2013-03-31 | 81,431 | USD | 274 |
| 2012-01-01 to 2012-03-31 | 571 | USD | 91 |
| 2011-07-01 to 2012-03-31 | 2,795 | USD | 275 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2013-03-31 | 1,266,209 | USD | 274 |
| 2011-07-01 to 2012-03-31 | 1,049,634 | USD | 275 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2013-03-31 | -897,120 | USD | 274 |
| 2011-07-01 to 2012-03-31 | -666,933 | USD | 275 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | -32,712,938 | USD | |
| At 2012-06-30 | -31,931,685 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 692 | USD | |
| At 2012-06-30 | 1,270 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | -139,415 | USD | 90 |
| 2012-07-01 to 2013-03-31 | -840,824 | USD | 274 |
| 2012-01-01 to 2012-03-31 | -73,723 | USD | 91 |
| 2011-07-01 to 2012-03-31 | -634,563 | USD | 275 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 1,637,592 | USD | |
| At 2012-06-30 | 1,126,455 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | -237 | USD | 90 |
| 2012-07-01 to 2013-03-31 | -713 | USD | 274 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 211,419 | USD | |
| At 2012-06-30 | 168,351 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | 166,787 | USD | 90 |
| 2012-07-01 to 2013-03-31 | 916,239 | USD | 274 |
| 2012-01-01 to 2012-03-31 | 73,145 | USD | 91 |
| 2011-07-01 to 2012-03-31 | 634,517 | USD | 275 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 2,094 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | 27,372 | USD | 90 |
| 2012-07-01 to 2013-03-31 | 75,415 | USD | 274 |
| 2012-01-01 to 2012-03-31 | -578 | USD | 91 |
| 2011-07-01 to 2012-03-31 | -46 | USD | 275 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | 5,786 | USD | 90 |
| 2012-07-01 to 2013-03-31 | 29,736 | USD | 274 |
| 2012-01-01 to 2012-03-31 | 12,386 | USD | 91 |
| 2011-07-01 to 2012-03-31 | 60,746 | USD | 275 |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 4,621,430 | USD | |
| At 2012-06-30 | 4,621,430 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | -112,731 | USD | |
| At 2012-06-30 | -102,053 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | -244,357 | USD | |
| At 2012-06-30 | -198,704 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | -130,606 | USD | 90 |
| 2012-07-01 to 2013-03-31 | -826,906 | USD | 274 |
| 2012-01-01 to 2012-03-31 | -73,723 | USD | 91 |
| 2011-07-01 to 2012-03-31 | -631,439 | USD | 275 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | -115,674 | USD | 90 |
| 2012-07-01 to 2013-03-31 | -781,253 | USD | 274 |
| 2012-01-01 to 2012-03-31 | -57,373 | USD | 91 |
| 2011-07-01 to 2012-03-31 | -579,412 | USD | 275 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | 160,798 | USD | 90 |
| 2012-07-01 to 2013-03-31 | 885,936 | USD | 274 |
| 2012-01-01 to 2012-03-31 | 60,591 | USD | 91 |
| 2011-07-01 to 2012-03-31 | 573,042 | USD | 275 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2013-03-31 | 602 | USD | 274 |
| 2011-07-01 to 2012-03-31 | 526 | USD | 275 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2013-03-31 | 223 | USD | 274 |
Inspect the source
- Entity
- SANGUI BIOTECH INTERNATIONAL INC / CIK 0001104280
- Captured
- SEC response SHA-256
80929a3d07bdd3be99cfb5858d464edb9844d0e622d958ee5dce9515baeeed6f
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001104280.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))